To the best of our knowledge, this is the first study to investigate the association between serum IGF2BP3 and type 2 diabetes risk in subjects with a high risk of T2DM, offering some novel interesting clues for the clinical predictive value of serum IGF2BP3 in T2DM. Here, IGF2BP3 is linked to type 2 diabetes mellitus.